日科化学(300214.SZ)：上半年净利润115.61万元

Core Viewpoint - The company reported significant revenue growth in the first half of 2025, indicating strong operational performance despite a slight decline in net profit [1] Financial Performance - The company achieved operating revenue of 1.957 billion yuan, representing a year-on-year increase of 37.04% [1] - The net profit attributable to shareholders was 1.1561 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -123,600 yuan [1] - The basic earnings per share were 0.0025 yuan [1]